Revium Rx (RVRC) Market Capitalization (2024 - 2026)

Revium Rx has disclosed Market Capitalization across 3 years of filings, most recently posting $101.4 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 234.0% year-over-year to $101.4 million; the TTM figure through Jun 2026 stood at $101.4 million (up 234.0% YoY), while the FY2025 annual figure was $31.6 million, up 30.0% from the prior year.
• Market Capitalization came in at $101.4 million for Q2 2026 at Revium Rx, up from $31.6 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $101.4 million in Q2 2026 to a low of $24.3 million in Q4 2024.
• Average Market Capitalization over 3 years is $46.9 million, with a median of $31.0 million recorded in 2025.
• Year-over-year, Market Capitalization gained 30.0% in 2025 and soared 234.0% in 2026.
• Over 3 years, Market Capitalization stood at $24.3 million in 2024, then climbed by 30.0% to $31.6 million in 2025, then jumped by 221.15% to $101.4 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $101.4 million in Q2 2026, $31.6 million in Q4 2025, and $30.4 million in Q2 2025.